ArticleCancer gene therapy2021

Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours.

Kenneth Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.